TCL Archive In Brief: Lame Ducks continue On NCAB; Calabresi Elected To IOM; Ravikumar Moves To Yale September 28, 1990
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results October 24, 1986
TCL Archive In Brief: Whittaker Corp, Trying To Hire NCI Director; Environmental Carcinogenesis On NCAB Agenda February 13, 1976
